Find the right fit for you - faster
Get tailored insights about working at ArborGen in one quick step.
ArborGen Snapshot
ArborGen's seedlings are a chip off the ol' bioengineering block. The company produces and markets genetically enhanced eucalyptus and pine tree seedlings designed to grow quickly and resist frigid temperatures and disease. The company, which also offers conventional seedlings, typically markets to customers in the US, New Zealand, and Australia. While sold directly to core customers like large land owners and managers, its trees are ultimately used by pulp and paper products producers and companies in the biopower, charcoal, and biofuels industries. ArborGen operates a dozen nurseries, 15 orchards, three R&D facilities, and several distribution centers. In mid-2011 the company shelved its plans to go public.
